Literature DB >> 12721941

Severe inflammation and reduced bacteria load in murine helicobacter infection caused by lack of phagocyte oxidase activity.

Thomas G Blanchard1, Feiwen Yu, Chen-Lung Hsieh, Raymond W Redline.   

Abstract

The vaccine-induced immune mechanisms that protect against Helicobacter pylori infection in the mouse model have not been identified. This study investigated the contribution of reactive oxygen and nitrogen intermediates to Helicobacter pathogenesis and immunity. Mice deficient in nicotinamide-adenine dinucleotide phosphate oxidase activity (gp91(phox-/-)), nitric oxide synthase activity (NOS2(-/-)), or both (gp91(phox-/-)/NOS2(-/-)) were infected with Helicobacter organisms and evaluated for inflammation and bacteria load. Infection of all 3 transgenic strains resulted in significantly more inflammation than found in infected C57BL/6 wild-type mice. However, only gp91(phox-/-) and gp91(phox-/-)/NOS2(-/-) mice had significantly reduced numbers of infected gastric glands. Intranasal immunization of NOS2(-/-) or gp91(phox-/-)/NOS2(-/-) mice against H. pylori resulted in protective immunity comparable to that seen in C57BL/6 control mice. Therefore, reactive oxygen species may play a role in limiting the inflammatory response associated with H. pylori infection of the gastric mucosa but may also limit the host's ability to eradicate Helicobacter organisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12721941     DOI: 10.1086/374780

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

Review 1.  Are reactive oxygen species always detrimental to pathogens?

Authors:  Claudia N Paiva; Marcelo T Bozza
Journal:  Antioxid Redox Signal       Date:  2013-10-26       Impact factor: 8.401

Review 2.  Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.

Authors:  Holly M Scott Algood; Timothy L Cover
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Decreased STAT5 phosphorylation and GATA-3 expression in NOX2-deficient T cells: role in T helper development.

Authors:  Kristen E Shatynski; Haiyan Chen; Jaeyul Kwon; Mark S Williams
Journal:  Eur J Immunol       Date:  2012-10-01       Impact factor: 5.532

Review 4.  Vaccinating against Helicobacter pylori in the developing world.

Authors:  Shamila Zawahir; Steven J Czinn; John G Nedrud; Thomas G Blanchard
Journal:  Gut Microbes       Date:  2013-11-06

5.  Chemotaxis Allows Bacteria To Overcome Host-Generated Reactive Oxygen Species That Constrain Gland Colonization.

Authors:  Kieran D Collins; Shuai Hu; Helmut Grasberger; John Y Kao; Karen M Ottemann
Journal:  Infect Immun       Date:  2018-04-23       Impact factor: 3.441

6.  Vaccine-induced immunity against Helicobacter pylori in the absence of IL-17A.

Authors:  Elizabeth S DeLyria; John G Nedrud; Peter B Ernst; Mohammad S Alam; Raymond W Redline; Hua Ding; Steven J Czinn; Jinghua Xu; Thomas G Blanchard
Journal:  Helicobacter       Date:  2011-06       Impact factor: 5.753

7.  Role of NADPH phagocyte oxidase in host defense against acute respiratory Acinetobacter baumannii infection in mice.

Authors:  Hongyu Qiu; Rhonda Kuolee; Greg Harris; Wangxue Chen
Journal:  Infect Immun       Date:  2008-12-22       Impact factor: 3.441

Review 8.  Polyamine- and NADPH-dependent generation of ROS during Helicobacter pylori infection: A blessing in disguise.

Authors:  Alain P Gobert; Keith T Wilson
Journal:  Free Radic Biol Med       Date:  2016-09-25       Impact factor: 7.376

9.  Early Molecular Events in Murine Gastric Epithelial Cells Mediated by Helicobacter pylori CagA.

Authors:  Aditi Banerjee; Malini Basu; Thomas G Blanchard; Subba R Chintalacharuvu; Wei Guang; Erik P Lillehoj; Steven J Czinn
Journal:  Helicobacter       Date:  2016-01-28       Impact factor: 5.753

10.  Cytokine-dependent regulation of NADPH oxidase activity and the consequences for activated T cell homeostasis.

Authors:  Divya Purushothaman; Apurva Sarin
Journal:  J Exp Med       Date:  2009-06-22       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.